Add to Basket
Order hotline:
![]() |
+1 404 474 4654 |
![]() |
+1 888 205 9894 (TF) |
Oxidized Low Density Lipoprotein (Lectin-Like) Receptor 1 (OLR1) antibody
| Antigen | Oxidized Low Density Lipoprotein (Lectin-Like) Receptor 1 (OLR1) |
| Synonyms | OLR1, LOX1, CLEC8A, SCARE1 |
| Clonality | Polyclonal |
| Host |
Alternatives Sheep |
| Reactivity |
Alternatives Human |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunoprecipitation (IP), Western Blotting (WB), Flow Cytometry (FACS) |
![]() |
3 references available |
| Catalog no. | ABIN121884 |
| Quantity | 50 µg (0.1 mg/ml) |
| Price | 473.00 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 6 to 8 Business Days |
Additional Information
| Alternative name | OLR1 / LOX1 |
| UniProt | P78380 |
| Immunogen | Recombinant human extracellular domain LOX-1 protein from bacteria |
| Cross-Reactivity | Human |
| Description | LOX-1 is a 40-50kDa class E scavenger receptor, expressed by endothelial cells, macrophages, activated platelets and smooth muscle cells. LOX-1 binds to a wide range of ligands, including oxidized low-density lipoprotein (oxLDL), hypochlorite modified high-density lipoprotein (HDL), aged/apoptotic cells, activated platelets and bacteria, reflecting its versatile physiological functions. Expression of the LOX-1 gene is upregulated by oxLDL and the binding of LOX-1 to oxLDL results in the activation of NF-kappaB. Furthermore, LOX-1 antibodies have been shown to suppress the oxidized HDL (oxHDL) activation of NF-KappaB in endothelial cells, suggesting that this activation may be due to the binding of oxHDL to LOX-1. Angiotensin II and the inflammatory cytokine Tumour Necrosis Factor alpha (TNFalpha) also invoke an increase in LOX-1 gene expression and studies have focused on its role in endothelial dysfunction (1,4) and inflammatory diseases such as atherosclerosis (1) and rheumatoid arthritis, as well as its affect on CD40/CD40L signaling in both atherosclerosis and human coronary artery endothelial cells (HCAECs). Alternate Names: LOX1, lectin-like oxidized LDL receptor-1. |
Application Details
| Application Notes | Immunohistochemistry on frozen sections. Immunoprecipitation. Flow Cytometry: 1:10, Use 10ul of the suggested working dilution to label 10e6 cells in 100ul. Western Blot: 1:10 - 1/100, This antibody detects intact 50kDa LOX-1 and also a prominent 32kDa proteolytic fragment in western blotting. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user. |
| Concentration | 0.1 mg/ml |
| Purification | Purified |
| Buffer | PBS, pH 7.4 containing 0.09% Sodium Azide and 1% Bovine Serum Albumin |
| Storage | Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf Life: one year from despatch. |
| Restrictions | For Research Use only |
Publications
|
Yoshida, Kondratenko, Green et al.: "Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor." in: The Biochemical journal, Vol. 334 ( Pt 1), pp. 9-13, 1998 (PubMed).
Morawietz, Rueckschloss, Niemann et al.: "Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein." in: Circulation, Vol. 100, Issue 9, pp. 899-902, 1999 (PubMed). Li, Liu, Chen et al.: "LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 23, Issue 5, pp. 816-21, 2003 (PubMed). |
|
Alternatives
Alternatives for antigen "Oxidized Low Density Lipoprotein (Lectin-Like) Receptor 1 (OLR1)", type "Antibodies"




Alternatives